首页 › 基金 › Invenomic Capital Management LP › KR
Invenomic Capital Management LP 对 KR 的持仓历史
KROGER CO · 日常消费
Invenomic Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 KR(KROGER CO)238,295 股,市值约 US$14.0M,约占其申报组合的 0.69%,在其申报持仓中市值排名第 49 位。 Invenomic Capital Management LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Invenomic Capital Management LP 对 KR 的持仓演变
Invenomic Capital Management LP 于 Q3 2026 首次披露 KR 持仓:238,295 股(约 US$14.0M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 238.29K | $13.97M | 新进 |
关于 KR 与 13F 数据
KR(KROGER CO)属于日常消费行业。我们追踪的基金中还有 24 只申报持有 KR,申报仓位最大的包括:伯克希尔·哈撒韦 (US$2.05B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Invenomic Capital Management LP
常见问题
How long has Invenomic Capital Management LP held KR?
Invenomic Capital Management LP has disclosed KR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Invenomic Capital Management LP's current position in KR?
As of Q3 2026, Invenomic Capital Management LP holds 238.29K shares of KR (KROGER CO), valued at $13.97M, representing 0.69% of its reported portfolio and ranking #49.
Has Invenomic Capital Management LP been buying or selling KR?
In the latest 13F filing (Q3 2026), Invenomic Capital Management LP newly opened its position in KR.
Which other funds hold KR?
Other major institutional holders of KR include 伯克希尔·哈撒韦, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.